<DOC>
	<DOCNO>NCT01685671</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetics CKD-11101 NESP SC administration health male volunteer</brief_summary>
	<brief_title>Pharmacokinetics Study CKD-11101 NESP After SC Administration Health Male Volunteers</brief_title>
	<detailed_description>Healthy volunteer administrate CKD-11101 60μg NESP 60μg subcutaneously . ( crossover ) Every time take medication , PK parameter safety CKD-11101 60μg NESP 60μg perform use blood sample conduct test ( Laboratory test , V/S Physical Examination , etc ) respectively .</detailed_description>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Signed informed consent form prior study participation . A healthy male volunteer 20 55 year old . Body weight 55kg 90kg , BMI 18 27 . Appropriate subject study judging investigator ( physical examination , laboratory test , interview , etc . ) Have medical history allergic disease include hypersensitivity drug clinically significant allergic disease Clinically significant hepatic , renal , respiratory system , endocrine system , nervous system , immune system , hematologic , psychiatric , circulatory system , tumor history tumor Have abnormal laboratory result . Hemoglobin &lt; 12g/dL &gt; 17g/dL Vitamin B12 &lt; 200pg/mL Ferritin &lt; 21.8ng/mL Transferrin &lt; 190mg/dL Reticulocyte normal limit Positive Triage TOX drug urine ( cocaine , amphetamine , barbiturate , opiate , benzodiazepine , cannabinoids ) Positive HIV antibody , HBsAg , HCV antibody test A heavy smoker ( cigarette &gt; 10 cigarette per day ) Administer EPO , darbepoetin , immunoglobulin IV iron within 3 month prior first IP administration Have hypersensitivity reaction history EPO , darbepoetin , excipient IP iron tablet sit SBP &lt; 90mmHg sit SBP &gt; 140mmHg sit DBP &lt; 55mmHg sit DBP &gt; 90mmHg Pulse rate &gt; 100 per/min History hemoglobinopathy inflammatory disease drug abuse within 6 month screen Subject take ethical drug herbal medicine within 14 day , OTC vitamin supplement within 7 day first IP administration Participated clinical trial administrate IP within 8 week prior first IP administration A heavy alcohol consumer ( alcohol &gt; 21 units/week ) stop drink Bleed donate blood ( &gt; 400mL ) within 8 week first IP administration Participated clinical trial administrate IP Have diet within 2 day first IP administration stop food contain grapefruit food contain caffeine Disagree avoid get pregnant clinical trial An impossible one participate clinical trial investigator 's decision include laboratory test result , reason</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>CKD-11101</keyword>
	<keyword>NESP</keyword>
	<keyword>Darbepoetin alfa</keyword>
	<keyword>Anemia</keyword>
	<keyword>subcutaneous</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Phase 1</keyword>
</DOC>